Basilea Pharmaceutica AG
BPMUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $77,593 | $10,451 | $12,147 | -$6,831 |
| Dep. & Amort. | $1,732 | $1,577 | $1,097 | $754 |
| Deferred Tax | $0 | $0 | $1,138 | $1,948 |
| Stock-Based Comp. | $5,066 | $4,762 | $3,598 | $4,322 |
| Change in WC | $9,373 | -$5,225 | -$11,380 | -$33,309 |
| Other Non-Cash | -$19,401 | $2,680 | $456 | $1,096 |
| Operating Cash Flow | $74,363 | $14,245 | $7,056 | -$32,020 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,710 | -$813 | -$3,303 | -$860 |
| Net Acquisitions | $781 | $0 | $0 | -$1,603 |
| Inv. Purchases | $0 | $0 | $0 | -$35,000 |
| Inv. Sales/Matur. | $0 | $0 | $94,951 | $41,038 |
| Other Inv. Act. | -$82 | -$221 | $1 | $0 |
| Investing Cash Flow | -$1,011 | -$1,034 | $91,649 | $3,575 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$15,603 | -$59,314 | $73,875 | -$23,212 |
| Stock Issued | $2,439 | $2,390 | $4,426 | $44,106 |
| Stock Repurch. | $0 | -$381 | $0 | -$4,254 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$123,547 | $0 |
| Financing Cash Flow | -$13,164 | -$57,305 | -$45,246 | $16,640 |
| Forex Effect | $50 | -$151 | $155 | $501 |
| Net Chg. in Cash | $60,238 | -$44,245 | $53,614 | -$11,303 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $64,322 | $108,567 | $54,953 | $66,256 |
| End Cash | $124,560 | $64,322 | $108,567 | $54,953 |
| Free Cash Flow | $72,571 | $13,211 | $3,753 | -$32,880 |